- Home
- FGNX vs SGMO Comparison
FGNX vs SGMO Comparison
Compare FGNX & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | SGMO |
|---|---|---|
| Founded | 1932 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.4M | 135.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | FGNX | SGMO |
|---|---|---|
| Price | $3.01 | $0.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $8.50 | $5.60 |
| AVG Volume (30 Days) | 557.1K | ★ 4.3M |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,450,000.00 | ★ $32,875,000.00 |
| Revenue This Year | $95.83 | N/A |
| Revenue Next Year | $42.41 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 144.71 | N/A |
| 52 Week Low | $2.30 | $0.37 |
| 52 Week High | $41.25 | $1.40 |
Technical Indicators
Market Signals| Indicator | FGNX | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.13 |
| Support Level | N/A | $0.37 |
| Resistance Level | N/A | $0.48 |
| Average True Range (ATR) | 0.00 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 30.36 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.